Hat mitgewirkt an:
-
Entwicklung von (¹²³/¹³¹I)IMAZA als Theranostikum für Nebennierentumore
-
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K
-
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K